# Alta Partners: portfolio, investments and team

> Alta Partners is a vc firm based in United States. 150 investments on record, latest Nov 2019. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/alta-partners (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Alta Partners

Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet New fund, May 2023 VC firm

Seed Series A Series B Connected Health Healthier Living Healthtech

Follow Alta Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Falta-partners)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 150 on record

Since the last cheque **2550** days **00** hrs **00** min **00** sec

Median round **$33M** Cheque size, as they say **$100K – $5.0M** Rounds led **0 of 150** Sole investor **2 rounds** Exits **26 from the portfolio** Mostly in **United States, 93%**

Pitch Alta Partners

## Alta Partners highlights

- 01 150 rounds on record
- 02 Mostly Series B and Series C: 51% of its rounds
- 03 Sole investor in 2 rounds, median $23M
- 04 26 exits from the portfolio

## What they do

> Alta Partners is a leading healthcare and life sciences venture capital firm From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $100K – $5.0M as they say
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Connected Health Healthier Living Healthtech
- **Based in:** Jackson, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **150 appearances**

- **2019** 2 rounds
- **Nov** **[eGenesis](https://millionrounds.com/company/egenesis)** Series B · US · FinSMEs **$100M** With 6 others
- **May** **[DispatchHealth](https://millionrounds.com/company/dispatchhealth)** US · FinSMEs **$33M** With 2 others
- **2017** 1 round
- **Sept** **[DispatchHealth](https://millionrounds.com/company/dispatchhealth)** US · FinSMEs **$31M** With 1 other
- **2014** 7 rounds
- **Sept** **[Allakos](https://millionrounds.com/company/allakos)** Series A · US **$10M** With 3 others
- **Aug** **[Allakos](https://millionrounds.com/company/allakos)** Series A · US **$25M** With 3 others
- **Aug** **[St. George's University](https://millionrounds.com/company/st-george-s-university)** Growth · GD **$750M** With 1 other
- **Jul** **[Virobay](https://millionrounds.com/company/virobay)** Series B · US **$8.0M** With 4 others
- **Mar** **[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Series B · US **$45M** With 6 others
- **Mar** **[ZS Pharma](https://millionrounds.com/company/zs-pharma)** Series D · US **$55M** With 8 others
- **Feb** **[Lithera](https://millionrounds.com/company/lithera)** Series C · US **$8.0M** With 2 others
- **2013** 9 rounds
- **Dec** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series D · US · finsmes.com **$26M** With 5 others
- **Dec** **[Zafgen](https://millionrounds.com/company/zafgen)** Series E · US · finsmes.com **$45M** With 3 others
- **Oct** **[Immune Design](https://millionrounds.com/company/immune-design)** Series C · US · finsmes.com **$49M** With 6 others
- **Jul** **[aTyr Pharma](https://millionrounds.com/company/atyr-pharma)** Series D · US · finsmes.com **$49M** With 3 others
- **May** **[Kite Pharma](https://millionrounds.com/company/kite-pharma)** Series A · US · fiercebiotech.com **$20M** Sole investor
- **May** **[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Series A · US · reuters.com **$23M** With 2 others
- **Apr** **[Esperion Therapeutics](https://millionrounds.com/company/esperion-therapeutics)** Venture · US · businesswire.com **$33M** With 5 others
- **Mar** **[Achaogen](https://millionrounds.com/company/achaogen)** Series D · US **$19M** With 6 others
- **Jan** **[Carbylan Therapeutics](https://millionrounds.com/company/carbylan-therapeutics)** Series B · US · altapartners.com **$6.0M** With 2 others
- **2012** 7 rounds
- **Dec** **[Allakos](https://millionrounds.com/company/allakos)** Venture · US · sec.gov **$10.0M** With 4 others
- **Dec** **[Lithera](https://millionrounds.com/company/lithera)** Series C · US · lithera.com **$21M** With 4 others
- **Dec** **[Zafgen](https://millionrounds.com/company/zafgen)** Series D · US · masshightech.com **$21M** With 2 others
- **Nov** **[Kiadis Pharma](https://millionrounds.com/company/kiadis-pharma)** Venture · NL · kiadis.com **$13M** With 4 others
- **Nov** **[Applied Genetics Technologies Corporation](https://millionrounds.com/company/applied-genetics-technologies-corporation)** Series B · US · biospace.com **$38M** With 5 others
- **Oct** **[ZS Pharma](https://millionrounds.com/company/zs-pharma)** Series C · US · bizjournals.com **$46M** With 5 others
- **May** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series C · US · finance.yahoo.com **$17M** With 4 others
- **2011** 4 rounds
- **Jul** **[SARcode Bioscience](https://millionrounds.com/company/sarcode-bioscience)** Series B · US · finsmes.com **$44M** With 3 others
- **Mar** **[Aerie Pharmaceuticals](https://millionrounds.com/company/aerie-pharmaceuticals)** Series B · US · sec.gov **$41M** With 4 others
- **Feb** **[Chimerix](https://millionrounds.com/company/chimerix)** Series F · US · chimerix-inc.com **$45M** With 7 others
- **Jan** **[PneumRx](https://millionrounds.com/company/pneumrx)** Venture · US · finsmes.com **$33M** With 7 others
- **2010** 14 rounds
- **Nov** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series C · US · finsmes.com **$37M** With 4 others
- **Oct** **[aTyr Pharma](https://millionrounds.com/company/atyr-pharma)** Series C · US · atyrpharma.com **$23M** With 3 others
- **Oct** **[Pathwork Diagnostics](https://millionrounds.com/company/pathwork-diagnostics)** Series C · US · fis.dowjones.com **$30M** With 5 others
- **Jul** **[Immune Design](https://millionrounds.com/company/immune-design)** Series B · US · xconomy.com **$32M** With 4 others
- **Jul** **[Cerenis Therapeutics](https://millionrounds.com/company/cerenis-therapeutics)** Series C · FR · cerenis.com **$52M** With 6 others
- **Jul** **[Cara Therapeutics](https://millionrounds.com/company/cara-therapeutics)** Series D · US · fiercebiotech.com **$15M** With 7 others
- **Jul** **[Trevena](https://millionrounds.com/company/trevena)** Series B · US · onbiovc.com **$35M** With 3 others
- **Jun** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series C · US · calistogapharma.com **$40M** With 5 others
- **Jun** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series E · US · onbiovc.com **$20M** With 6 others
- **Jun** **[Virobay](https://millionrounds.com/company/virobay)** Series B · US · deals.venturebeat.com **$10M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **7 named**

BS **Bob S. More** Manager of General Partner i Filing they signed

DS **Daniel Spencer Janney** Managing Member of the General Partner i Filing they signed

LS **Larry S. Randall** Chief Financial Officer i Filing they signed

LE **Laurence Eliot Randall** CFO i Form ADV

PS **Pete S. Hudson** Manager of General Partner i Filing they signed

PA **Peter Alan Hudson** Partner i Form ADV

RJ **Robert Joseph More** Partner i Form ADV

We also hold **14** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$665M** gross assets of its funds, 2 advisers combined Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** ALTA Partners Management Company, L.P.
- **SEC number:** CRD 288423

## What they claim to have backed

From their own portfolio page (on their website)

**9** of 19 we have independently watched raise

[Curasen](https://millionrounds.com/company/curasen)[Dembiopharma](https://millionrounds.com/company/dem-biopharma)[Dispatchhealth](https://millionrounds.com/company/dispatchhealth)[Harborhealth](https://millionrounds.com/company/harbor-health)[Lassentherapeutics](https://millionrounds.com/company/lassen-therapeutics)[Patientslikeme](https://millionrounds.com/company/patientslikeme)[Qihanbio](https://millionrounds.com/company/qihan-biotech)[Transcarent](https://millionrounds.com/company/transcarent)[Variantbio](https://millionrounds.com/company/variant-bio) Alta Partners NextGen Egenesisbio Freemarkethealth Kymathera Marathon Progentos Scithera Tyra Umpartners Vir

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **26 in all**

**[ZS Pharma](https://millionrounds.com/company/zs-pharma)** Bought by [AstraZeneca](https://millionrounds.com/fund/astrazeneca) **$2.7B** Nov 2015

**[PneumRx](https://millionrounds.com/company/pneumrx)** Bought by [BTG](https://millionrounds.com/fund/btg) **$475M** Dec 2014

**[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Bought by [Shire](https://millionrounds.com/fund/shire) **$260M** May 2014

**[Aerie Pharmaceuticals](https://millionrounds.com/company/aerie-pharmaceuticals)** Listed **Undisclosed** Oct 2013

**[Ceregene](https://millionrounds.com/company/ceregene)** Bought by Sangamo BioSciences **Undisclosed** Aug 2013

**[Tacit Knowledge](https://millionrounds.com/company/tacit-knowledge)** Bought by Newgistics **Undisclosed** Aug 2013

**[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Listed **$100M** May 2013

**[SARcode Bioscience](https://millionrounds.com/company/sarcode-bioscience)** Bought by [Shire](https://millionrounds.com/fund/shire) **$160M** Mar 2013

**[nCircle Network Security](https://millionrounds.com/company/ncircle-network-security)** Bought by Tripwire **Undisclosed** Mar 2013

**[Aegis Lightwave](https://millionrounds.com/company/aegis-lightwave)** Bought by Photop Technologies **Undisclosed** Jan 2013

**[Xelerated](https://millionrounds.com/company/xelerated)** Bought by [Marvell Technology](https://millionrounds.com/fund/marvell-technology) **Undisclosed** Apr 2012

**[Excaliard Pharmaceuticals](https://millionrounds.com/company/excaliard-pharmaceuticals)** Bought by Excaliard Pharmaceuticals **Undisclosed** Nov 2011

**[Plexxikon](https://millionrounds.com/company/plexxikon)** Bought by [Daiichi Sankyo](https://millionrounds.com/fund/daiichi-sankyo) **$935M** Feb 2011

**[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Bought by [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) **$375M** Feb 2011

**[Taligen Therapeutics](https://millionrounds.com/company/taligen-therapeutics)** Bought by [Alexion Pharmaceuticals](https://millionrounds.com/fund/alexion-pharmaceuticals) **$111M** Jan 2011

**[Avid Radiopharmaceuticals](https://millionrounds.com/company/avid-radiopharmaceuticals)** Bought by [Eli Lilly](https://millionrounds.com/fund/eli-lilly) **$800M** Nov 2010

**[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Sept 2010

**[Coapt Systems](https://millionrounds.com/company/coapt-systems)** Bought by MicroAire **Undisclosed** Aug 2010

**[Intradigm Corporation](https://millionrounds.com/company/intradigm-corporation)** Bought by [Silence Therapeutics](https://millionrounds.com/fund/silence-therapeutics) **Undisclosed** Dec 2009

**[Biovitrum](https://millionrounds.com/company/biovitrum)** Bought by [Swedish Orphan Biovitrum](https://millionrounds.com/fund/swedish-orphan-biovitrum) **$493M** Nov 2009

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**Raised**

a new fund in May 2023

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$33M** the round, not its cheque Alone, median **$23M**

Led 0 of 150 rounds **0%**

- **Said size:** $100K – $5.0M
- **Sole investor:** 2 rounds
- **Last cheque:** Nov 2019
- **Exits:** 26 from the portfolio

Rounds by stage said on their site

- Series B said *39*
- Series C *33*
- Venture *21*
- Series D *21*
- Series A said *19*
- Series E *8*
- Seed said *-*

Cheques by year Led Joined

2001 2019

Often in the room with

- [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) 13
- [Gimv](https://millionrounds.com/fund/gimv) 12
- [Venrock](https://millionrounds.com/fund/venrock) 11
- [HBM BioVentures](https://millionrounds.com/fund/hbm-bioventures) 10
- [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 10
- [Domain Associates](https://millionrounds.com/fund/domain-associates) 9

**Pitching Alta Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Alta Partners. A count of rooms they were both in, not a relationship either has claimed.

[**Frazier Healthcare Partners** Private equity **13** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Gimv** Private equity **12** rounds together](https://millionrounds.com/fund/gimv)[**Venrock** VC firm **11** rounds together](https://millionrounds.com/fund/venrock)[**HBM BioVentures** Growth equity **10** rounds together](https://millionrounds.com/fund/hbm-bioventures)[**Versant Ventures** VC firm **10** rounds together](https://millionrounds.com/fund/versant-ventures)[**Domain Associates** VC firm **9** rounds together](https://millionrounds.com/fund/domain-associates)[**RiverVest** VC firm **9** rounds together](https://millionrounds.com/fund/rivervest-venture-partners)[**Atlas Venture** VC firm **8** rounds together](https://millionrounds.com/fund/atlas-venture)[**Clarus Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/blackstone)[**InterWest Partners** VC firm **8** rounds together](https://millionrounds.com/fund/interwest-partners)[**New Enterprise Associates** VC firm **8** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**OrbiMed** Private equity **8** rounds together](https://millionrounds.com/fund/orbimed)

## Recently backed

The latest companies Alta Partners put money into.

[**DispatchHealth** $33M · May 2019](https://millionrounds.com/company/dispatchhealth)

## Mentioned on podcasts

Episodes that name Alta Partners in their description, not their title.

- [Growth Investor](https://millionrounds.com/podcasts/growth-investor) 8 Feb 2023 · 18 min Delivering A Better Healthcare Experience: Everside Health CEO Chris Miller Mentions [Alta Partners](https://millionrounds.com/fund/alta-partners)[Greenspring Associates](https://millionrounds.com/fund/greenspring-associates)[New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) Apple PodcastsShow page

## Quick answers about Alta Partners

### What does Alta Partners invest in?

Alta Partners invests most often at Series B and Series C (51% of the rounds on record), in sectors such as Connected Health, Healthier Living and Healthtech.

### How active is Alta Partners?

150 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2019.

### What has Alta Partners invested in recently?

Its most recent investments on record: eGenesis (Series B, Nov 2019) and DispatchHealth (Undisclosed round, May 2019).

### How big are Alta Partners's cheques?

The median round it joins is $33M. It says it writes cheques of $100K to $5.0M.

### Does Alta Partners lead rounds?

Rarely, if at all: none of its 150 investments on record names it as the lead.

### Where does Alta Partners invest?

Most of the companies it backs are in the United States (93%).

### Is Alta Partners investing now?

No investments in the last 12 months; the latest was in Nov 2019.

### Who does Alta Partners invest alongside?

Most often Frazier Healthcare Partners (13 rounds together), Gimv (12 rounds together) and Venrock (11 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=alta-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=alta-partners)